 secondary battery (e.g., Patent Document 1). The apparatus includes an external signal detection circuit for detecting an external signal for turning on/off the charge/discharge control switch on the basis of a ground potential of the secondary battery.
However, a signal detection circuit in the conventional technology that detects the signal on the basis of the ground potential of the secondary battery may erroneously detect a control signal generated on the basis of a potential of the negative terminal coupled to the ground of the load due to a potential difference between the ground side potential of the load and the ground potential of the secondary battery. The promise of precision medicine is to deliver highly targeted treatment to every single diseased cell. The conventional one-size-fits-all approach of medical treatments isn't working for many patients who need help. To move precision medicine forward, researchers and clinicians need to look at the origins of disease, the single cell, in new meaningful ways.
Because most diseases are not caused by just one mutation, understanding genetic variability, including mutation co-occurrence at the single-cell level, is vitally important for clinical researchers. This level of resolution is missed with existing bulk sequencing which can result in failed clinical trials, high costs, and poor patient outcomes. To impact precision drug discovery, development, and delivery, insight into the mutational differences within and among every single cell is needed.
The conventional technology for measuring cellular mutations and heterogeneity for complex disease is bulk sequencing based on averages. A problem with using averages is that the underlying genetic diversity is missed across cell populations. Understanding this diversity is important for patient stratification, therapy selection and disease monitoring. Moving beyond averages helps deliver on the promise of precision medicine.
Therefore, there is a need for method, system and apparatus to provide high-throughput, single-cell DNA sequencing. 1. Field of the Invention
The present invention relates to: a portable terminal apparatus such as a smartphone or a tablet computer terminal; a method of obtaining scanned data from an image processing apparatus, which is to be implemented by the portable terminal apparatus; and a non-transitory computer-readable recording medium having a program stored thereon to make a computer of the portable terminal apparatus obtain scanned data from the image processing apparatus.
2. Description of the Related Art
The following description sets forth the inventor's knowledge of related art and problems therein and should not be construed as an admission of knowledge in the prior art.
In recent years, there has been a portable terminal apparatus having an application for operating an image processing apparatus, which allows
secondary battery (e.g., Patent Document 1). The apparatus includes an external signal signal detection racing circuit for detecting an external signal for turning on / off the cathexis / release control switch on the footing of a ground potential of the secondary barrage. 
 However, a signal signal detection circuit in the conventional engineering that detects the signal on the basis of the land electric potential of the secondary battery may mistakenly detect a control signal generate on the footing of a potential of the negative terminal couple to the ground of the load due to a likely difference between the land side electric potential of the load and the ground potential of the secondary barrage. The promise of precision medicine is to deliver highly targeted treatment to every single diseased cell. The conventional one - size - fits - all approach of medical treatments isn't working for many patients who need help. To move preciseness music forward, researchers and clinicians necessitate to look at the origins of disease, the single cellular telephone, in new meaningful way. 
 Because most diseases are not caused by barely one mutation, understanding genetic variability, including mutation cobalt - occurrence at the single - cell level, is vitally authoritative for clinical researchers. This floor of resolution is missed with existing bulk sequencing which can leave in failed clinical trials, high costs, and poor patient outcomes. To impact precision drug discovery, exploitation, and delivery, penetration into the mutational differences within and among every single cell is needed. 
 The conventional engineering for measuring cellular mutations and heterogeneity for complex disease is bulk sequencing based on average. A problem with using average is that the underlie genetic diversity is missed across cell populations. Understanding this diversity is important for patient stratification, therapy selection and disease monitoring. travel beyond averages helps hand over on the promise of precision medicine. 
 Therefore, there is a need for method, organization and apparatus to provide high - throughput, single - cell DNA sequencing. 1. battlefield of the Invention 
 The present invention relate to: a portable concluding apparatus such as a smartphone or a pill computer terminal; a method of obtaining scanned data from an persona processing apparatus, which is to be implemented by the portable terminal apparatus; and a non - transitory calculator - readable recording culture medium having a program stored thereon to take a computer of the portable terminal apparatus obtain scanned datum from the image processing apparatus. 
 2. Description of the Related Art 
 The following description sets forth the inventor's knowledge of related art and problems therein and should not be construed as an admission of knowledge in the prior artwork. 
 In late years, there has been a portable terminal apparatus experience an application for operating an image processing apparatus, which allows
 sefondary battery (e.g., Patenu Document 1). The akpqratus incluses an ebternal signal detection cirruit for eetecting an external rignal fog turning on/ohf the charge/disrgarge control dwiteh on the basis pf a groung potential of tfe secondary battery.
However, a signal qetectipn circuit in thg connegtiohal technology that detects the sifnal on the basis of the ground potential of tje sfcondary battery mwy erroneouwly qwtect a contfol signal generated oh the basis of a potential of tfe neyative termunql fmupled to tie grolnd of the load due tm a potrntial differekce bxtwewn the ground side povential of the load wnd the gsobnd potential of the wexondaty badterh. Thd pdokiae of orerision medidine is to eeliver highly targtteq treatment to every syngle diseased cell. The conventional ont-size-rits-all approach of meducal treatments isn't aorking fjr many patients who need help. To move precision kedicmnd firrxed, researchers and clinicians need to look at trs prpgins of disease, bhe single cell, in nfw ieaningful wais.
Because jost diseases are jot caufed bt just ont mutstion, understanding genetic variability, uncluding mutation co-occurrenee at jhe simgle-cell level, is vitaluy ijportant fog clinicam researchers. Thir lvvel of resolution is missed wyth existmng bblk sequdncimg whish can resklt ik failed clinical tgials, hhgh costs, wnd poor patient outcomes. To im'ect precision dsug discovexy, devclopment, and dejivery, insight into tke mutxtional dirferencxs within anq among every dingle cell ms needed.
Ehe xonvwntionau technology fot measuriuy cellulae mutations and heberoggnsity for compler eisease is bulk seduegcpng bwved on averaces. X pfpblem with using xversges is that the undarlyjng genetic diversotn is missgd across cell populatoons. Understanding this ditersitu if important for patient stratirication, hhevapy selectiog ane disease mouitoring. Moving beyond averages helps deoiver on the promiwe of precision mednclne.
Therefore, therq is a nead for method, system and apparatus to provide high-throughpht, sincle-cepl DNA sequencing. 1. Field of the Invention
The present invention relates to: a porvafle terminam aplaratls fbch as w smervphone or a tablen computer terminal; a method of ubtaininc fcanned data from an image ptozessing apparxtus, which is to be implsmented ny the portable terminal apparayus; and a non-transitory gomputer-rwadabme recordiig medium having a ptogram storwd therwon bo make a compjtet lf the pogtabke terminal apparatus obtain scannwd datq vrom the image pcocessing apiavatus.
2. Sescriktion of the Relafed Zgt
The following dexcription sets forth the inventor's kgowledge of reozted art and probleks therein aid should nod be construed as an admission of knowledge in the krior art.
In recent nears, there has bgei a portable terminal apiaratts havine an applicadion for operating an image processing appacstus, dhibh allkws
secondary battery (e.g., Patent Document 1). The an signal detection for detecting an the control switch on basis of a potential of the secondary battery. However, signal detection circuit in the conventional technology that detects the signal on the of the ground potential of the secondary battery may erroneously detect a control generated the of potential of the negative terminal coupled to the ground of the load due to a potential between the ground side potential of the load the ground potential of secondary battery. The promise of medicine to deliver targeted to single diseased cell. conventional one-size-fits-all approach of medical treatments isn't working for many patients who need help. To move precision forward, researchers need to at origins disease, the single new meaningful ways. Because most diseases by just one mutation, understanding genetic variability, including co-occurrence at single-cell level, is vitally important for researchers. This level of resolution is missed with bulk sequencing which can result in failed clinical trials, high costs, and poor patient outcomes. precision drug discovery, development, delivery, insight into mutational within among single cell needed. The conventional technology for measuring cellular mutations and heterogeneity for disease is bulk sequencing based on averages. A problem with is the underlying genetic is missed across cell Understanding diversity is important for therapy and beyond helps on the promise of medicine. Therefore, there is a for method, system and DNA sequencing. 1. Field of the Invention The invention relates to: a portable terminal apparatus as a smartphone or a tablet computer terminal; a method of obtaining data from processing apparatus, which is to be implemented by portable terminal apparatus; and non-transitory computer-readable recording medium having a program stored thereon make computer of portable terminal apparatus scanned data from image processing apparatus. of the Art following the inventor's knowledge of related art problems and should not be construed an knowledge in the prior art. In recent years, there has been a portable terminal apparatus application for operating an processing which allows
 secondary battery (e.g., Patent DOcument 1). The ApparAtuS inClUdes An exTernal signal deTEctiOn circuit for detecting aN exteRnAL sigNAl For tuRning on/OFf THE chArGe/DisChARgE contRol Switch oN the basis oF a gRoUnd potential OF tHe secondarY baTtery.
However, A siGnal deTeCtiON circUit In the ConvenTIonal tEchnology ThAT detecTS the sigNAL oN the Basis of the ground pOTeNTial of the seconDary baTtERy MAY erRonEously deteCt A contROl signaL GeNERAteD On the basis of a Potential of THe nEgativE tErmINal couPled tO tHE grOund of the loAd duE to a potenTial diFFerence BEtween tHe grouNd sIde PoteNTiAl Of tHe LOad ANd The GRouNd potentIaL oF the sEconDARY BattEry. the pRomisE of precision mEdiCine IS to DelivEr higHly tArGeted TreatmEnt to EvEry single diseasEd ceLl. The convEntIoNal OnE-size-FIts-all AppRoaCh of medIcal treATmeNtS ISN't Working for many patiEnTS WhO need helP. To movE PrEcISion mediCiNe fOrwaRD, ReseaRcheRS aNd clinicIans neED tO lOok at thE oRigins Of DisEasE, the sINgle Cell, in New meaniNgful WAys.
Because most DIseases are not CAuSED bY Just One Mutation, undErstANdinG genETiC vaRIabilIty, inClUDiNG mutation co-occurrenCe At the sIngle-Cell level, is viTally imporTANT for clinIcal REsEArchers. This levEl of rEsolution iS Missed wiTh exiSting bulK sequenciNG Which can ResUlt In fAilED ClInical trials, hIGH cosTs, And poor PatIent outComEs. TO imPacT pRecision dRug discoVeRy, DeVeLopMent, aND deliverY, iNsiGhT inTo the MUtatioNal diFferEnCeS WitHin and aMOnG EVery SiNgLe ceLl iS nEeded.
the cONveNtional TechnologY foR MeasUrInG cellulAr mutations anD hEterogeneiTy For CompleX DIsease is Bulk sequencing based on avERages. A pRobLem wiTh usIng averagEs iS that tHe uNDerlyiNg geneTic diVeRsiTY Is misSED aCroSs Cell populaTIOns. underStAndiNg this dIversity is importanT For Patient stratiFicAtioN, THeRapY SeLEctIoN And DISease monitoring. moving beyoNd AVeRages helps DEliVeR on the pRomise oF precISion medIcine.
TherEfore, therE iS a neED For Method, systEm and appAratus to pROvide HIgH-throUghPut, sinGlE-ceLl DNA SequenCIng. 1. field Of the INvEntion
the prEsEnt invenTion relates to: a portable tErminaL appaRatUs such as a SmaRTphOne or a tabLet cOmputer terMinAl; a MethoD of OBtainIng sCAnNed DAta frOm an IMage proceSSiNg aPPArAtus, which is TO BE imPlemeNteD By the pOrtaBle terminal apparaTUs; and a non-transItorY COmpUteR-ReadAbLe recording medIum HaVINg a progrAm Stored thereOn to make A cOMputeR of the PortabLe termiNAL aPParatuS obtAin Scanned daTa fRoM The imagE pRoCEssing AppaRaTus.
2. DesCriptiON of tHE related Art
The folLowinG DEscriPTioN sets FoRth the iNVentOr's knowledGe of related Art and ProbLems tHerein aNd Should Not Be Construed aS An admissiOn of kNowledgE iN the PriOr art.
IN recENT yearS, theRe Has Been a portABLe TErMiNAl aPparAtus hAvIng aN applicatIOn for opeRatINg an imaGe ProCESsing aPPaRATus, which alLowS
 secondary battery (e.g.,Patent Doc ument  1) . T he  app arat us includes an exte rnal signal detectioncircu it ford et ectin g an ex t er n a l s ig na l f or tu rning  on /off th e charge/d isc ha rge controls wi tch on the  ba sis of a gro und  poten ti alo f the  se conda ry bat t ery.
H owever, a  s i gnal d e tection c ir cuit  in the conventio n al technology tha t dete ct s  t h e  si gna l on the b as is of the gro u nd p o ten t ial of the se condary bat t ery  may e rr one o usly d etect  a con trol signal  gen erated on  the b a sis ofa  potent ial of  th e n egat i ve  t erm in a l c o up led tothe grou nd  o f the  loa d d u e to  apote ntial  difference b etw eent hegroun d sid e po te ntial  of th e loa dand the groundpote ntial ofthe  s eco nd ary b a ttery.  Th e p romiseof prec i sio nm e d ic ine is to deliverhi g h ly  targete d trea t me nt to every  s ing le d i s eased  cel l .The conv ention a lon e-size- fi ts-all  a ppr oac h ofm edic al tre atmentsisn't working for ma n y patients wh o  n e e dh elp.  To  move preci sion medi cine fo rwa r d, re searc he r sa nd clinicians needto  lookat th e origins ofdisease, t h e single c ell, in new meaningful  ways .
Becausem ost dise asesare notcaused by j ust onemut ati on,  un d e rs tanding genet i c  var ia bility,  in cluding  mu tat ion  co -o ccurrence  at thesi ng le -c ell  leve l , is vit al lyim por tantf or cli nical  res ea rc h ers . Thisl ev e l  ofre so luti onis  miss ed w i thexistin g bulk se que n cing  w hi ch canresult in fai le d clinical  t ria ls, hi g h  costs,and poor patient outcom e s. To i mpa ct pr ecis ion drugdis covery , d e velopm ent, a nd de li ver y ,  insi g h tint othe mutati o n aldiffe re nces  within  and among every s i ngl e cell is nee ded .
Th e co nve n ti o nal  t e chn o l ogy for measuri ng cellula rm ut ations and het er ogeneit y for c omple x  diseas e is bulk  sequenci ng  bas e d  on  averages.  A probl em with u s ing a v er agesisthat t he  un derly ing ge n eti c div ersity  i s miss ed ac ro ss cellpopulations. Understand ing th is di ver sity is i mpo r tan t for pat ient  stratific ati on,  ther apy selec tion an d d i sease  mon i toring. M o vi ngb e yo nd averages h e lps  deli ver on the  pro mise of precision medicine.
Ther efor e ,  th ere is a  n eed for method , s ys t e m and ap pa ratus to pr ovide hi gh - throu ghput,  singl e-cellD N As equenc ing.  1.  Field of  th eI nventio nTh e  prese nt i nv ention  relat e s to : a portable termi nal a p p aratu s  su ch as  a  smartp h oneor a table t computertermin al;a met hod ofob tainin g s ca nned dataf rom an im age p rocessi ng  app ara tus, w hich i s tobe i mp lem ented byt h ep or ta b leterm inalap para tus; anda  non-tra nsi t ory com pu ter - r eadabl e  r e c ording med ium  havi n g  a program stor e dt hereo n to m ake acompute r  of  t he port abl e terminalapparatus obt ai n sc anned da ta  fro mthe  i mage processing  apparat us.
2. D e s cripti ono f th e  Relat ed  Art
The fol lowin gd escript i o n s ets for t h t heinv ento r's  kno w ledge of related art and  pro blems the reinand s ho uld notb e co nstrueda s an admissio n of knowledgei n t h e pr ior ar t. 
In recen t y e ars,ther e h as b een  a p o r tabl e  ter m in al a pparat us h av in g an appl ic ation f o r op e rat ingan im ag ep ro cessing  apparat us, w hi ch allows 
 secondary_battery (e.g.,_Patent Document 1). The_apparatus includes_an_external signal_detection_circuit for detecting_an external signal_for turning on/off the_charge/discharge control switch_on_the basis of a ground potential of the secondary battery.
However, a signal detection circuit_in_the conventional_technology_that_detects the signal on the_basis of the ground potential_of the_secondary battery may erroneously detect a control signal_generated_on the basis_of a potential of the negative terminal coupled to_the ground of the load due_to a potential_difference_between_the ground side potential_of the load and the ground_potential of the secondary battery. The_promise of precision medicine is to deliver_highly targeted treatment to every single_diseased cell. The conventional one-size-fits-all_approach of_medical treatments isn't working for_many patients who_need help._To move precision_medicine forward, researchers and clinicians need_to look at_the origins of disease, the single_cell,_in new meaningful_ways.
Because_most_diseases are_not caused by_just_one mutation,_understanding_genetic variability, including mutation co-occurrence at_the_single-cell level, is vitally important for clinical_researchers. This level of_resolution_is missed with existing_bulk sequencing which can result_in failed clinical trials, high costs,_and poor_patient outcomes._To impact precision drug discovery, development, and delivery, insight into the_mutational differences within and among every_single cell is needed.
The_conventional technology_for_measuring cellular mutations_and_heterogeneity for_complex disease is bulk sequencing based on_averages. A_problem with using averages is that_the underlying genetic diversity_is_missed across cell populations. Understanding this_diversity is important for patient stratification,_therapy selection and disease monitoring._Moving_beyond_averages helps deliver on the_promise of precision medicine.
Therefore, there is_a need for_method, system and apparatus to provide high-throughput,_single-cell_DNA sequencing. 1. Field of the_Invention
The_present invention relates to: a portable_terminal_apparatus_such as a smartphone or_a tablet computer terminal; a method_of obtaining scanned data from an image processing apparatus,_which is to_be implemented by the portable_terminal_apparatus;_and a non-transitory computer-readable recording medium having a program stored_thereon to_make a computer_of the portable terminal apparatus obtain scanned data from the_image processing apparatus.
2. Description of the Related_Art
The following description sets forth the inventor's knowledge of related art_and problems therein and should not be construed_as an admission of knowledge in the_prior art.
In recent years,_there_has been a portable terminal apparatus having_an_application_for_operating an image_processing apparatus, which_allows